<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.3" -->
<?xml-stylesheet href="http://www.w3.org/2000/08/w3c-synd/style.css" type="text/css"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <title>Engineering News | Chemicals &amp; Pharmaceuticals</title>
        <description><![CDATA[Latest news on chemicals and pharmaceuticals.]]></description>
        <link>https://www.engineeringnews.co.za/page/chemicals-pharmaceuticals</link>
        <lastBuildDate>Thu, 04 Jun 2026 23:41:56 +0200</lastBuildDate>
        <generator>FeedCreator 1.7.3</generator>
        <item>
            <title>Africa CDC and Aspen Pharmacare aim to boost vaccine output in Africa</title>
            <link>https://www.engineeringnews.co.za/article/africa-cdc-and-aspen-pharmacare-aim-to-boost-vaccine-output-in-africa-2026-05-12</link>
            <description><![CDATA[The African Union's public health agency and South African drugmaker Aspen Pharmacare are in talks on a long‑term framework aimed at boosting vaccine production on the continent, after the Covid‑19 pandemic exposed its overreliance on imports. Africa Centres for Disease Control and Prevention (Africa CDC) and the continent's largest pharmaceutical company said on Tuesday the talks are focused on building viable markets for vaccines produced in Africa as part of efforts to improve health security and reduce the continent's reliance on imports.]]></description>
            <author>  Reuters</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Tue, 12 May 2026 14:47:00 +0200</pubDate>
        <a_id>721091</a_id>
        <updated>1778591484</updated>
        <published>1778590020</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001271238_resized_vaccine1covid19coronavirus1022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Aspen to release first commercial batches of locally-made human insulin </title>
            <link>https://www.engineeringnews.co.za/article/aspen-to-release-first-commercial-batches-of-locally-made-human-insulin-2026-05-05</link>
            <description><![CDATA[JSE-listed Aspen Pharmacare has received approval from the South African Health Products Regulatory Authority and will start the release of the first commercial batches of human insulin manufactured for sale in South Africa, under a previously announced agreement with Novo Nordisk. The products were manufactured at Aspen’s sterile finished dose form manufacturing facility in Gqeberha, in the Eastern Cape.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Tue, 05 May 2026 13:08:00 +0200</pubDate>
        <a_id>720561</a_id>
        <updated>1777980613</updated>
        <published>1777979280</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001269755_resized_aspenssvp2facilityinportelizabeth11020211022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Adcock Ingram Critical Care, Olympus partner to expand medical innovation in Southern Africa</title>
            <link>https://www.engineeringnews.co.za/article/adcock-ingram-critical-care-olympus-partner-to-expand-medical-innovation-in-southern-africa-2026-04-24</link>
            <description><![CDATA[Adcock Ingram Critical Care (AICC), a manufacturer and supplier of hospital and critical care products in Southern Africa, and global medical technology company Olympus have entered into a strategic partnership to strengthen their focus on improving patient care. The partnership will expand access to Olympus’ advanced endoscopy solutions and broader medical and surgical technologies across South Africa and the rest of the Southern African region.]]></description>
            <author>Sabrina Jardim</author>
            <category>MEDICAL</category>
            <pubDate>Fri, 24 Apr 2026 16:15:00 +0200</pubDate>
        <a_id>720105</a_id>
        <updated>1777040371</updated>
        <published>1777040100</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001268351_resized_adcockenapril1022.jpeg</image_url>
        <image_title>Olympus Middle East and Africa VP and MD Ronald Boueri and AICC MD Colin Sheen</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>ASP Isotopes expects first shipments of nuclear medicine, electronics isotopes in 2026</title>
            <link>https://www.engineeringnews.co.za/article/asp-isotopes-expects-first-shipments-of-nuclear-medicine-electronics-isotopes-in-2026-2026-04-13</link>
            <description><![CDATA[JSE- and Nasdaq-listed advanced materials company ASP Isotopes expects to dispatch the first commercial shipments of silicon-28 (Si-28), used to produce advanced electronics, and ytterbium-176 (Yb-176), which is used in nuclear medicine procedures, and carbon-14, which is used in chemical and biological research, during this year. Further, it expects to achieve Phase 1 nameplate production from the Virginia gas project in the third quarter of this year of 58 000 cubic feet a day of liquid helium and 2 500 GJ a day of liquefied natural gas (LNG).]]></description>
            <author>Schalk Burger</author>
            <category>SPECIALTY CHEMICALS</category>
            <pubDate>Mon, 13 Apr 2026 16:38:00 +0200</pubDate>
        <a_id>719184</a_id>
        <updated>1776104027</updated>
        <published>1776091080</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>SAHPRA to monitor Citro-Soda production standards following recall</title>
            <link>https://www.engineeringnews.co.za/article/sahpra-assures-public-of-actions-to-safeguard-against-gmp-noncompliance-at-adocks-citro-soda-production-line-2026-03-24</link>
            <description><![CDATA[The South African Health Products Regulatory Authority (SAHPRA) says it will continue to monitor the implementation of actions by pharmaceutical company Adcock Ingram at its Clayville, Gauteng, production facility to ensure the facility meets the necessary good manufacturing practices (GMP) standards. This follows the recall of several batches of Citro-Soda Regular products manufactured at the facility between April 2024 and December 2025.]]></description>
            <author>Chanel de Bruyn</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Tue, 24 Mar 2026 17:00:00 +0200</pubDate>
        <a_id>717942</a_id>
        <updated>1774360294</updated>
        <published>1774364400</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <attachments><attachment><url>https://cisp.cachefly.net/assets/articles/attachments/96361_citro_soda_recall_batch_details.pdf</url><size>321002</size><title>To download a list of the affected Citro-Soda Regular products, click here</title></attachment></attachments>
        <media:group><media:content url="https://cisp.cachefly.net/assets/articles/attachments/96361_citro_soda_recall_batch_details.pdf" fileSize="321002" type="video" medium="video" expression="full"><media:description type="plain">To download a list of the affected Citro-Soda Regular products, click here</media:description></media:content></media:group>
        </item>
        <item>
            <title>Necsa to tender for new multi-purpose research reactor</title>
            <link>https://www.engineeringnews.co.za/article/necsa-to-tender-for-new-multi-purpose-research-reactor-2026-03-24</link>
            <description><![CDATA[South African nuclear energy firm Necsa will soon launch the next phase of a tender for a new multi-purpose research reactor aimed at maintaining its position as a top global exporter of medical isotopes, its CEO told Reuters on Tuesday. The isotopes, used to diagnose and treat disorders such as cancer and heart disease, are created in small nuclear reactors dedicated to science and training rather than energy generation.]]></description>
            <author>  Reuters</author>
            <category>NUCLEAR RESEARCH</category>
            <pubDate>Tue, 24 Mar 2026 14:05:00 +0200</pubDate>
        <a_id>717946</a_id>
        <updated>1774355251</updated>
        <published>1774353900</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001261524_resized_untitled20260324t140941868.jpeg</image_url>
        <image_title>General view of Safari 1 that houses the nuclear research reactor at Necsa's Pelindaba facility</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Ledwaba resigns as Cilo Cybin CFO </title>
            <link>https://www.engineeringnews.co.za/article/ledwaba-resigns-as-cilo-cybin-cfo-2026-03-09</link>
            <description><![CDATA[Reshoketswe Maggy Ledwaba has resigned as CFO and executive director of JSE-listed Cilo Cybin, effective March 31. She will, however, remain with the company until April 30 to ensure an orderly transition and handover of responsibilities, including completion of its upcoming financial reporting period.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Mon, 09 Mar 2026 11:48:00 +0200</pubDate>
        <a_id>716855</a_id>
        <updated>1773055691</updated>
        <published>1773049680</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001258388_resized_cilocybincannabisplantflowerroomgabrieltheron0922donna.jpg</image_url>
        <image_title>Cilo Cybin cannabis plant flower room </image_title>
        <image_width>511</image_width>
        <image_height>383</image_height>
        </item>
        <item>
            <title>South Africa seeks local production of Gilead's HIV prevention drug</title>
            <link>https://www.engineeringnews.co.za/article/south-africa-seeks-local-production-of-gileads-hiv-prevention-drug-2026-03-05</link>
            <description><![CDATA[South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, domestically, in a push to bring production to the region where it is most needed.   The government is working alongside international partners, including Unitaid and the United States Pharmacopoeia, to identify which local company could make the twice-yearly injection safely, effectively and affordably, and provide any support needed. They will then recommend that company to Gilead.]]></description>
            <author>  Reuters</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Thu, 05 Mar 2026 08:45:00 +0200</pubDate>
        <a_id>716610</a_id>
        <updated>1772699157</updated>
        <published>1772693100</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001257626_resized_untitled318.jpeg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year</title>
            <link>https://www.engineeringnews.co.za/article/drugmaker-aspen-targets-mounjaro-approval-in-sub-saharan-africa-this-year-2026-03-04</link>
            <description><![CDATA[Aspen Pharmacare aims to secure sub‑Saharan African approval for Eli Lilly's blockbuster weight‑loss drug Mounjaro as early as this year, its CEO said on Wednesday, capitalising on soaring regional demand for obesity treatments. South Africa-based Aspen’s push to register Mounjaro across the region signals its bid to become a key manufacturing and distribution partner for global drugmakers eyeing one of the last major untapped markets for GLP‑1 weight‑loss treatments.]]></description>
            <author>  Reuters</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Wed, 04 Mar 2026 12:03:00 +0200</pubDate>
        <a_id>716560</a_id>
        <updated>1772621542</updated>
        <published>1772618580</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001257461_resized_untitled317.jpeg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>KAP claims price component of Safripol's ethylene supply dispute with Sasol has been determined ...</title>
            <link>https://www.engineeringnews.co.za/article/kap-claims-price-component-of-safripols-ethylene-supply-dispute-with-sasol-has-been-determined-in-its-favour-2026-03-02</link>
            <description><![CDATA[JSE-listed diversified industrial holding company KAP says that, in a dispute between polymer producer and KAP subsidiary Safripol and JSE-listed energy and chemicals company Sasol about an ethylene supply agreement, the dispute about the price of ethylene has now been determined in favour of Safripol with costs, and with KAP's interpretation of the pricing principles of the supply agreement being upheld by the arbitrator. This is a significant development for Safripol, KAP says.]]></description>
            <author>Schalk Burger</author>
            <category>CHEMICALS SUPPLY</category>
            <pubDate>Mon, 02 Mar 2026 14:26:00 +0200</pubDate>
        <a_id>716356</a_id>
        <updated>1772540888</updated>
        <published>1772454360</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Printing for health  products advances</title>
            <link>https://www.engineeringnews.co.za/article/printing-for-health-products-advances-2026-02-27</link>
            <description><![CDATA[Digital printing is the preferred solution when versioning, short runs and speed of production are key factors, and has been integral to a "breakthrough" by printing solutions provider Pyrotec PackMedia in addressing South African Health Products Regulatory Authority (SAHPRA) labelling requirements, says GM Timothy Beattie. South Africa’s health and wellness market mandates that packaging for vitamins, natural supplements or homeopathic remedies aligns with SAHPRA’s complementary medicines regulations and clearly communicates essential information.]]></description>
            <author>Halima Frost</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 27 Feb 2026 00:00:00 +0200</pubDate>
        <a_id>715146</a_id>
        <updated>1771917085</updated>
        <published>1772143200</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001253325_resized_packaginglabellingpyrotecpackmedia02261022.jpeg</image_url>
        <image_title>SUFFICIENT INFO
Multipage label printing facilitates regulatory compliance</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>AECI grows Ebitda, Ebitda margin; to invest in plants and equipment in 2026</title>
            <link>https://www.engineeringnews.co.za/article/aeci-grows-ebitda-ebitda-margin-to-invest-in-plants-and-equipment-in-2026-2026-02-25</link>
            <description><![CDATA[JSE-listed mining and chemicals multinational AECI posted revenue of R32.1-billion for the year ended December 31, 2025, which was down 4% on the prior year; however, it achieved record earnings before interest, taxes, depreciation and amortisation (Ebitda) of R3.4-billion and improved its Ebitda margin to 11% from 9% in the prior year. The company has concluded most of the disposals of noncore assets, and realised R2.2-billion from these disposals during the year under review. The discontinued operations also recorded a loss for the year of R15-million, down from a R560-million loss in the prior year.]]></description>
            <author>Schalk Burger</author>
            <category>FINANCIAL RESULTS</category>
            <pubDate>Wed, 25 Feb 2026 16:44:00 +0200</pubDate>
        <a_id>716070</a_id>
        <updated>1772033669</updated>
        <published>1772030640</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001255977_resized_aeciinterimceodeanmurrayjan261022.jpg</image_url>
        <image_title>AECI interim group CEO Dean Murray</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Competition Tribunal gives its approval for BASF coatings division buyout by Bond</title>
            <link>https://www.engineeringnews.co.za/article/competition-tribunal-gives-its-approval-for-basf-coatings-division-buyout-by-bond-2026-02-23</link>
            <description><![CDATA[The Competition Tribunal of South Africa has unconditionally approved the merger in which investment company Bond UK will acquire the coatings division of chemicals company BASF. Following the merger, Bond UK will have sole control of BASF’s coatings division.]]></description>
            <author>Schalk Burger</author>
            <category>MERGERS &amp; ACQUISITIONS</category>
            <pubDate>Mon, 23 Feb 2026 11:10:00 +0200</pubDate>
        <a_id>715830</a_id>
        <updated>1771838728</updated>
        <published>1771837800</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Aimia to complete secondary listing on JSE on February 24</title>
            <link>https://www.engineeringnews.co.za/article/aimia-to-complete-secondary-listing-on-jse-on-february-24-2026-02-18</link>
            <description><![CDATA[TSX-listed diversified conglomerate Aimia has received approval from the JSE and the financial surveillance department of the South African Reserve Bank (SARB) for a secondary listing on the main board of the local stock exchange under the Chemicals: Diversified subsector, from February 24. The JSE has granted approval to Aimia for a secondary listing by way of introduction under the fast-track secondary inward listing process, and the SARB approved the secondary inward listing of Aimia on the main board of the JSE and classified the secondary inward listed common shares as domestic for exchange control purposes.]]></description>
            <author>Schalk Burger</author>
            <category>CHEMICALS</category>
            <pubDate>Wed, 18 Feb 2026 12:26:00 +0200</pubDate>
        <a_id>715549</a_id>
        <updated>1771412746</updated>
        <published>1771410360</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Harper resigns from Sasol board</title>
            <link>https://www.engineeringnews.co.za/article/harper-resigns-from-sasol-board-2026-02-17</link>
            <description><![CDATA[JSE-listed chemicals and energy company Sasol says nonexecutive director Katherine Harper has tendered her resignation for personal reasons, which the board accepted on February 16. “On behalf of the board, I wish to express our sincere appreciation to Kathy for her dedicated service over the past six years. Her thoughtful insights, professionalism and valuable perspectives have enriched the board’s deliberations and made a meaningful contribution to our work.]]></description>
            <author>Schalk Burger</author>
            <category>EXECUTIVE APPOINTMENTS</category>
            <pubDate>Tue, 17 Feb 2026 12:34:00 +0200</pubDate>
        <a_id>715458</a_id>
        <updated>1771326181</updated>
        <published>1771324440</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Aspen delivers encouraging interim performance</title>
            <link>https://www.engineeringnews.co.za/article/aspen-delivers-encouraging-interim-performance-2026-02-12</link>
            <description><![CDATA[JSE-listed Aspen Pharmacare Holdings has reported that the group delivered an encouraging performance for the first half of its current financial year, supported by the continued strong momentum in commercial pharmaceuticals and solid progress in the reshaping of its sterile finished dose form (FDF) manufacturing facilities in South Africa and France. The company notes that one-off restructuring costs of about R700-million relating to these sterile FDF manufacturing facilities have been incurred in the first half of this year and have negatively impacted on earnings per share (EPS) and headline earnings per share (HEPS).]]></description>
            <author>Sabrina Jardim</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Thu, 12 Feb 2026 15:12:00 +0200</pubDate>
        <a_id>715171</a_id>
        <updated>1770906154</updated>
        <published>1770901920</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001253401_resized_aspenssvp2facilityinportelizabeth11020211022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Sasol warns of interim earnings plunge on the back of impairments, weak prices</title>
            <link>https://www.engineeringnews.co.za/article/sasol-warns-of-interim-earnings-plunge-on-the-back-of-impairments-weak-prices-2026-02-05</link>
            <description><![CDATA[JSE-listed Sasol has warned that its earnings for the six months ended December 31, 2025, are expected to fall sharply, with earnings per share (EPS) projected to decline by between 89% and 99% year-on-year, largely owing to weaker commodity prices and significant asset impairments. In a trading statement published on February 5, the company said EPS are expected to be between 10c and 80c, down from the EPS of R7.22 reported for the six months ended December 2024.]]></description>
            <author>Darren Parker</author>
            <category>CHEMICALS &amp; ENERGY</category>
            <pubDate>Thu, 05 Feb 2026 10:41:00 +0200</pubDate>
        <a_id>714599</a_id>
        <updated>1770283472</updated>
        <published>1770280860</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001251722_resized_sasolsecunda110221.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Ramaphosa touts his use of term ‘vaccine apartheid’ as a ‘crowning achievement’</title>
            <link>https://www.engineeringnews.co.za/article/ramaphosa-touts-his-use-of-term-vaccine-apartheid-as-a-crowning-achievement-2026-02-04</link>
            <description><![CDATA[President Cyril Ramaphosa has defended and expressed pride in his use of the term “vaccine apartheid” to describe global Covid-19 vaccine distribution, while analysts, historians and public health experts have raised concerns about the accuracy and implications of the comparison. Speaking at an event in Johannesburg on February 4, Ramaphosa said global vaccine access during the early stages of the Covid-19 pandemic represented a “most revolutionary moment”, arguing that wealthy countries in the northern hemisphere secured the vast majority of available doses and left Africa without access.]]></description>
            <author>Darren Parker</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Wed, 04 Feb 2026 16:00:00 +0200</pubDate>
        <a_id>714564</a_id>
        <updated>1770214664</updated>
        <published>1770213600</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001251622_resized_cyrilramaphosa210820231022.jpg</image_url>
        <image_title>President Cyril Ramaphosa</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Stricter regulatory scrutiny reshapes pharmaceutical logistics landscape</title>
            <link>https://www.engineeringnews.co.za/article/stricter-regulatory-scrutiny-reshapes-pharmaceutical-logistics-landscape-2026-01-26</link>
            <description><![CDATA[Heightened regulatory oversight of pharmaceutical distribution is reshaping South Africa’s logistics sector, placing increased emphasis on traceability, temperature control and secure handling across the healthcare supply chain. As compliance requirements tighten, logistics providers are being compelled to invest in specialised systems, infrastructure and skills to ensure that pharmaceutical products are distributed safely and conform with regulatory standards.]]></description>
            <author>Creamer Media Reporter  </author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Mon, 26 Jan 2026 08:00:00 +0200</pubDate>
        <a_id>713760</a_id>
        <updated>1770108684</updated>
        <published>1769407200</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>1</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001249201_resized_clement.jpg</image_url>
        <image_title>Clement Kgatla Bidvest International Logistics</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        <attachments><attachment><url>https://cisp.cachefly.net/assets/articles/attachments/96045_2026-01-19_bidvest_.mp4</url><size>177147108</size><title>Watch the At Top Level video in which Creamer Media publishing editor Martin Creamer talks to Bidvest International Logistics responsible pharmacist Clement Kgatla about the local pharmaceutical distribution landscape.</title></attachment></attachments>
        <media:group><media:content url="https://cisp.cachefly.net/assets/articles/attachments/96045_2026-01-19_bidvest_.mp4" fileSize="177147108" type="video" medium="video" expression="full"><media:description type="plain">Watch the At Top Level video in which Creamer Media publishing editor Martin Creamer talks to Bidvest International Logistics responsible pharmacist Clement Kgatla about the local pharmaceutical distribution landscape.</media:description></media:content></media:group>
<enclosure url="https://cisp.cachefly.net/assets/articles/attachments/96045_2026-01-19_bidvest_.mp4" length="177147108" type="video/mpeg" />        </item>
        <item>
            <title>Sasol reports Louisiana cracker plant restart, beneficial operation at South African destoning plant</title>
            <link>https://www.engineeringnews.co.za/article/sasol-reports-louisiana-cracker-plant-restart-beneficial-operation-at-south-african-destoning-plant-2026-01-22</link>
            <description><![CDATA[JSE-listed energy and chemicals company Sasol, reporting on its performance for the six months to December 31, 2025, says its Southern Africa destoning plant reached beneficial operation in December, while its integrated polyethylene cracker plant in Louisiana, in the US, was also restarted following an extended outage. During the period under review, Sasol remained focused on stable and reliable operational performance, while reinforcing the importance of safety in all aspects of operations.]]></description>
            <author>Schalk Burger</author>
            <category>ENERGY &amp; CHEMICALS</category>
            <pubDate>Thu, 22 Jan 2026 12:10:00 +0200</pubDate>
        <a_id>713625</a_id>
        <updated>1769079215</updated>
        <published>1769076600</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Unilever South Africa lifts local content to 80% as it moves to embed supply-chain resilience</title>
            <link>https://www.engineeringnews.co.za/article/unilever-south-africa-lifts-local-content-to-80-as-it-moves-to-embed-supply-chain-resilience-2025-12-08</link>
            <description><![CDATA[The producer of a diverse range of well-known household brands – from Sunlight soap and OMO washing powder, to Vaseline and Robertsons Spices – reports that it has increased the local content in the products it manufactures in South Africa to 80% from a level of only 40% in 2019. The brands are all produced by Unilever South Africa, which manufactures 95% of the products it sells locally.]]></description>
            <author>Terence Creamer</author>
            <category>MANUFACTURING</category>
            <pubDate>Mon, 08 Dec 2025 09:00:00 +0200</pubDate>
        <a_id>711571</a_id>
        <updated>1765188815</updated>
        <published>1765177200</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001243309_resized_justinapsey1022.jpeg</image_url>
        <image_title>Unilever South Africa MD Justin Apsey</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>ASP Isotopes founder Mann to resume CEO, chairperson duties from January</title>
            <link>https://www.engineeringnews.co.za/article/asp-isotopes-founder-mann-to-resume-ceo-chairperson-duties-from-january-2025-12-03</link>
            <description><![CDATA[JSE- and Nasdaq-listed isotopes production company ASP Isotopes has announced that its founder and executive chairperson Paul Mann will resume his role as CEO and continue as executive chairperson with effect from January 19, 2026. On September 29, the company announced that Mann would be taking a temporary leave of absence from his CEO duties for health reasons and that the board of directors had appointed ASP Isotopes COO Robert Ainscow to serve as interim CEO, in addition to his existing duties.]]></description>
            <author>Schalk Burger</author>
            <category>EXECUTIVE APPOINTMENTS</category>
            <pubDate>Wed, 03 Dec 2025 09:43:00 +0200</pubDate>
        <a_id>711374</a_id>
        <updated>1764749865</updated>
        <published>1764747780</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Digital dentistry technology company expands its presence in South Africa</title>
            <link>https://www.engineeringnews.co.za/article/digital-dentistry-technology-company-expands-its-presence-in-south-africa-2025-11-28</link>
            <description><![CDATA[Nasdaq-listed digital orthodontics and restorative dentistry technology company Align Technology (Align) has announced that it was expanding its presence in South Africa, including the appointment of a country manager. The company has a current global customer base of more than 291 000 doctors. “South Africa presents a growth opportunity for Align Technology, with increasing digital adoption, potential for development and rising demand for orthodontic treatments, driving the expansion of innovative dentistry solutions across the region,” explained company GM Middle East and Africa Angelo Maura. “In response, we are further strengthening our presence in South Africa with the same strategic focus areas on which we’ve built Align Technology’s global success: continuous innovation, doctor-led therapy, and product superiority.”]]></description>
            <author>Rebecca Campbell</author>
            <category>MEDICAL TECHNOLOGY</category>
            <pubDate>Fri, 28 Nov 2025 15:24:00 +0200</pubDate>
        <a_id>711149</a_id>
        <updated>1764338189</updated>
        <published>1764336240</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Gavi, Unicef sign deal to cut malaria vaccine price</title>
            <link>https://www.engineeringnews.co.za/article/gavi-unicef-sign-deal-to-cut-malaria-vaccine-price-2025-11-24</link>
            <description><![CDATA[Global vaccine alliance Gavi and its partner Unicef will pay 25% less for a new malaria vaccine made by the Serum Institute of India within roughly a year's time, allowing them to reach more children despite cuts in international aid. The deal will reduce the cost of the R21 vaccine to $2.99 a dose from around $4. Unicef buys the vaccines with funding from Gavi, a partnership that works with governments to immunise children in the world's poorest countries. Gavi estimates the price drop will save $90-million, which can fund 30-million more doses for up to 7-million more children over the next five years. Gavi raised $3-billion less than its target at a fundraising event earlier this year as international donors, led by the United States, focused on other priorities.]]></description>
            <author>  Reuters</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Mon, 24 Nov 2025 08:46:00 +0200</pubDate>
        <a_id>710605</a_id>
        <updated>1763993498</updated>
        <published>1763966760</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001240438_resized_ebolavaccine0819reuters1022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Bidvest International Logistics opens new pharmaceutical warehouse at OR Tambo airport</title>
            <link>https://www.engineeringnews.co.za/article/bidvest-international-logistics-opens-new-pharmaceutical-warehouse-at-or-tambo-airport-2025-11-19</link>
            <description><![CDATA[Transport and logistics company Bidvest International Logistics (BIL) has opened a new pharmaceutical warehouse in OR Tambo International Airport, in Ekurhuleni, east of Johannesburg, to meet the country’s growing demand for efficient, compliant and resilient healthcare distribution. The facility is accredited by national regulator the South African Health Products Regulatory Authority and can handle, store and distribute Schedule 0 to 6 medicines.]]></description>
            <author>Schalk Burger</author>
            <category>PHARMACEUTICAL LOGISTICS</category>
            <pubDate>Wed, 19 Nov 2025 15:51:00 +0200</pubDate>
        <a_id>710348</a_id>
        <updated>1763564955</updated>
        <published>1763560260</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Itac rejects rebate on copper sulphate after confirming local supply capacity</title>
            <link>https://www.engineeringnews.co.za/article/itac-rejects-rebate-on-copper-sulphate-after-confirming-local-supply-capacity-2025-11-18</link>
            <description><![CDATA[The International Trade Administration Commission of South Africa (Itac) has declined to create a rebate provision for copper sulphate used in the manufacture of animal feed, concluding that the domestic market is already served by a local producer with sufficient capacity. Itac initiated the investigation following a request from Trade, Industry and Competition Minister Parks Tau, who raised concerns that the recent duty increase on copper sulphate from 0% to 10% could have unintended consequences for the animal feed industry, which relies on the chemical as an input.]]></description>
            <author>Darren Parker</author>
            <category>AGRICULTURE</category>
            <pubDate>Tue, 18 Nov 2025 10:05:00 +0200</pubDate>
        <a_id>710187</a_id>
        <updated>1763458124</updated>
        <published>1763453100</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001239226_resized_enonlinecowfeed1120251022.jpeg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>South Africa starts trial of first self-made vaccine in 50 years</title>
            <link>https://www.engineeringnews.co.za/article/south-africa-starts-trial-of-first-self-made-vaccine-in-50-years-2025-11-11</link>
            <description><![CDATA[South Africa started a clinical trial for its oral cholera inoculation, the first developed from scratch locally in 50 years as President Cyril Ramaphosa has joined continent-wide calls for growing vaccine self-sufficiency. Less than 1% of the world’s vaccines are made in Africa, even as infectious diseases are the leading cause of death on the continent, especially in children younger than five. Only a handful of African countries have vaccine-production facilities, with South Africa and Senegal the sole nations in the region with capacity to make them from start to finish. If the trial is successful, the Biovac Institute — a partly State-owned developer — will sell the vaccine from 2028. Recent global outbreaks of the diarrhoeal disease have raised demand for inoculations.]]></description>
            <author>  Bloomberg</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Tue, 11 Nov 2025 14:31:00 +0200</pubDate>
        <a_id>709694</a_id>
        <updated>1762869277</updated>
        <published>1762864260</published>
        <expires>99999999999</expires>
        <editor>  Bloomberg</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001237851_resized_ebolavaccineswho1022reuters.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Mining, agriculture segments underpin Omnia’s strong interim performance </title>
            <link>https://www.engineeringnews.co.za/article/mining-agriculture-segments-underpin-omnias-strong-interim-performance-2025-11-10</link>
            <description><![CDATA[Chemicals group Omnia Holdings says it delivered a strong performance from its core mining and agriculture segments for the six months ended September 30, reflecting growth across diversified global markets. The group’s operating profit increased by 12% to R900-million from R802-million in the interim period of the prior financial year, while the margin increased to 8% from 7.3% despite the impact of extended supplier shutdowns.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>CHEMICALS</category>
            <pubDate>Mon, 10 Nov 2025 12:55:00 +0200</pubDate>
        <a_id>709592</a_id>
        <updated>1762783486</updated>
        <published>1762772100</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001237508_resized_businessinafricaenomniaseelangobalsamy1020211022.jpg</image_url>
        <image_title>CEO Seelan Gobalsamy </image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Multi-port valve block now available</title>
            <link>https://www.engineeringnews.co.za/article/multi-port-valve-block-aids-biotechnological-pharmaceutical-operations-2025-11-07</link>
            <description><![CDATA[International valve specialist GEMÜ is expanding its single-use range with the GEMÜ Multiport SUMONDO multi-port valve block, which is available with pneumatic or manual block locking. The GEMÜ Multiport SUMONDO combines several individual single-use diaphragm valves in one multi-port valve block, offering a new solution for applications in pharmaceutical and biotechnological industries.]]></description>
            <author>Trent Roebeck</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 07 Nov 2025 00:00:00 +0200</pubDate>
        <a_id>708374</a_id>
        <updated>1762238026</updated>
        <published>1762466400</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001233788_resized_gemuemultiportsumondooct20251022.png</image_url>
        <image_title>MULTI-PORT SUMONDO VALVE
The multi-port valve offers a new solution for applications in the pharmaceutical and biotechnological industries
</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Aspen to receive R500m payment to settle manufacturing dispute</title>
            <link>https://www.engineeringnews.co.za/article/aspen-to-receive-r500m-payment-to-settle-manufacturing-dispute-2025-10-31</link>
            <description><![CDATA[JSE-listed pharmaceutical company Aspen will receive €25-million, or about R500-million, on December 1, in full and final settlement of a contractual dispute. The dispute, the details of which are subject to contractual confidentiality, relates to a manufacturing and technology agreement with a contract manufacturing customer for messenger RNA, mRNA, products.]]></description>
            <author>Schalk Burger</author>
            <category>CONTRACT DISPUTES</category>
            <pubDate>Fri, 31 Oct 2025 10:54:00 +0200</pubDate>
        <a_id>708985</a_id>
        <updated>1761902445</updated>
        <published>1761900840</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>SPAR Health acquires Aptekor Group, to build nationwide healthcare network</title>
            <link>https://www.engineeringnews.co.za/article/spar-health-acquires-aptekor-group-to-build-nationwide-healthcare-network-2025-10-23</link>
            <description><![CDATA[Retailer SPAR Group’s pharmacy subsidiary SPAR Health has acquired pharmaceutical wholesaler Aptekor Group, which is mainly based in the Western Cape, with the aim to build a nationwide healthcare network that is locally rooted and nationally supported. SPAR Health’s growing pharmacy network, called Pharmacy at SPAR, currently includes 125 stores nationwide, and it has plans to reach 250 stores within the next three years, says SPAR Health MD Jeremy Nicol.]]></description>
            <author>Schalk Burger</author>
            <category>MERGERS &amp; ACQUISITIONS</category>
            <pubDate>Thu, 23 Oct 2025 10:20:00 +0200</pubDate>
        <a_id>708394</a_id>
        <updated>1761208741</updated>
        <published>1761207600</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001233842_resized_sparhealthmdjeremynicol10251022.jpg</image_url>
        <image_title>SPAR Health MD Jeremy Nicol</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>CHIETA elects new accounting authority board, reappoints Pillay as CEO</title>
            <link>https://www.engineeringnews.co.za/article/chieta-elects-new-accounting-authority-board-reappoints-pillay-as-ceo-2025-10-17</link>
            <description><![CDATA[Sector education and training authority the Chemical Industries Education and Training Authority (CHIETA) says a new CHIETA Accounting Authority has been appointed by Higher Education and Training Minister Buti Manamela with effect from September 30. He also reappointed Yershen Pillay as CHIETA CEO until March 31, 2030, while the Accounting Authority will be led by interim chairperson Gerhard Cloete.]]></description>
            <author>Schalk Burger</author>
            <category>EXECUTIVE APPOINTMENTS</category>
            <pubDate>Fri, 17 Oct 2025 15:47:00 +0200</pubDate>
        <a_id>708031</a_id>
        <updated>1760710094</updated>
        <published>1760708820</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001232822_resized_yershenpillaychieta10221.jpg</image_url>
        <image_title>CHIETA CEO Yershen Pillay</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Aspen wins approval to market Lilly's Mounjaro for weight loss in South Africa</title>
            <link>https://www.engineeringnews.co.za/article/aspen-wins-approval-to-market-lillys-mounjaro-for-weight-loss-in-south-africa-2025-10-13</link>
            <description><![CDATA[Aspen Pharmacare said on Monday it had secured regulatory approval to market Eli Lilly's blockbuster diabetes and obesity drug, Mounjaro, for chronic weight management in South Africa. The greenlight follows Aspen's earlier approval and launch of the drug, chemically called tirzepatide, in South Africa last December as a treatment for Type 2 diabetes.]]></description>
            <author>  Reuters</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Mon, 13 Oct 2025 11:38:00 +0200</pubDate>
        <a_id>707580</a_id>
        <updated>1760351153</updated>
        <published>1760348280</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001231517_resized_untitled216.jpeg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Team Europe commits investment package of €11.5bn to South Africa</title>
            <link>https://www.engineeringnews.co.za/article/team-europe-commits-115bn-of-investment-to-south-africa-2025-10-10</link>
            <description><![CDATA[South African President Cyril Ramaphosa and European Commission President Ursula von der Leyen on October 9 unveiled a Team Europe investment package worth nearly €12-billion, at the Global Gateway Forum, in Brussels, Belgium. Through Global Gateway, Team Europe – the EU, its member States and development finance institutions – is mobilising an €11.5-billion investment package with South Africa.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>FINANCE AND RENEWABLE ENERGY</category>
            <pubDate>Fri, 10 Oct 2025 12:21:00 +0200</pubDate>
        <a_id>707494</a_id>
        <updated>1760101917</updated>
        <published>1760091660</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001231208_resized_cyrilramaphosaursulavonderleyen1025reuters1022.jpeg</image_url>
        <image_title>South African President Cyril Ramaphosa and European Commission President Ursula von der Leyen </image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Things to look out for at Electra Mining Africa 2026</title>
            <link>https://www.engineeringnews.co.za/article/things-to-look-out-for-at-electra-mining-africa-2026-2025-10-10</link>
            <description><![CDATA[Biennial tradeshow Electra Mining Africa 2026 will introduce a host of new features, including a brand new Orange Zone area that will be situated in the Arena at the Expo Centre, more theme days, and a new mascot. Electra Mining organisers Montgomery Group Africa portfolio director Charlene Hefer explains that, because there was insufficient outside space for exhibitors in 2024, opening up this space for a new zone will accommodate those additional exhibitors who want to exhibit outside. “This adds to the existing Red, Blue, Green and Yellow Zones outside.”]]></description>
            <author>Nadine James</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 10 Oct 2025 00:00:00 +0200</pubDate>
        <a_id>706422</a_id>
        <updated>1759130888</updated>
        <published>1760047200</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001228089_resized_electraminingafrica2026mascotcropped1022.jpg</image_url>
        <image_title>NEW MASCOT
The honey badger was chosen because “no creature better embodies the qualities that define mining and industry: toughness, resilience, adaptability and innovation in the face of challenge – the honey badger never backs down, and neither does the mining and industrial sector”.</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Analysers, meters on show at ﻿EMA can help ﻿remedy water concerns</title>
            <link>https://www.engineeringnews.co.za/article/analysers-meters-on-show-at-electra-can-help-address-water-concerns-2025-10-10</link>
            <description><![CDATA[Environmental, social and governance (ESG) mandates, sustainability worries, and the “very real impacts of climate change and water scarcity in South Africa”, have resulted in a noticeable increase in demand for on-line metal analysers for liquids, says Royce Water Systems (RWS) director Jacques Franken. Given the realities around climate change and ongoing challenges relating to the provision, stewardship and use of water in South Africa, this increased interest is likely to persist, which is why it is particularly apt that RWS – a division of Action Instruments – will be showcasing SEIBOLD heavy metal analysers, as well as the WESS Global sludge level and density meters at Electra Mining Africa 2026.]]></description>
            <author>Nadine James</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 10 Oct 2025 00:00:00 +0200</pubDate>
        <a_id>706400</a_id>
        <updated>1779710290</updated>
        <published>1760047200</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001228076_resized_roycewateranalysersept20251022.jpg</image_url>
        <image_title>HEAVY METAL SOLUTION
SEIBOLD Wasser researches, designs and develops products and services for continuous quantitative analysis of heavy metals in water, including aluminium, arsenic, cadmium, chromium, cobalt, copper, iron, manganese, and mercury among others</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Software provider to showcase benefits of strategic partnership</title>
            <link>https://www.engineeringnews.co.za/article/software-provider-to-showcase-benefits-of-strategic-partnership-at-ema26-2025-10-10</link>
            <description><![CDATA[Following a successful debut as a first-time exhibitor at Electra Mining Africa 2024 – where the company showcased its Hexagon Partner Solutions – software solutions provider Chempute Software is excited to return to one of Africa’s leading trade shows in 2026.   “This time, Chempute will highlight its strategic partnership with Datacor, featuring a unified suite of engineering tools including CHEMCAD, Fathom, Arrow, Impulse and xStream,” says Chempute marketing and business service manager Lee-Anne Kylander. ]]></description>
            <author>Nadine James</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 10 Oct 2025 00:00:00 +0200</pubDate>
        <a_id>706337</a_id>
        <updated>1779710324</updated>
        <published>1760047200</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001232101_resized_creamermediadatacor1022.jpg</image_url>
        <image_title>OPTIMISED OPERATIONS
Chempute will highlight its strategic partnership with Datacor, featuring a unified suite of engineering tools including CHEMCAD, Fathom, Arrow, Impulse and xStream</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>BASF appoints new MD in South Africa</title>
            <link>https://www.engineeringnews.co.za/article/basf-appoints-new-md-in-south-africa-2025-10-01</link>
            <description><![CDATA[Wojciech Kulma has been announced as chemical company BASF’s new MD in South Africa with immediate effect. The multinational company said on October 1 that this strategic leadership transition was in support of BASF’s ‘Winning Ways’ strategy, focused on value creation, customer proximity and performance-driven transformation across Southern Africa.]]></description>
            <author>Darren Parker</author>
            <category>CHEMICALS</category>
            <pubDate>Wed, 01 Oct 2025 14:03:00 +0200</pubDate>
        <a_id>706806</a_id>
        <updated>1759322214</updated>
        <published>1759320180</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Cannabis group Cilo Cybin lists on JSE main board </title>
            <link>https://www.engineeringnews.co.za/article/cannabis-group-cilo-cybin-lists-on-jse-main-board-2025-09-29</link>
            <description><![CDATA[Medical cannabis investment company Cilo Cybin Holdings has listed on the main board of the JSE as a fully-fledged trading entity, after listing as the first cannabis special purpose acquisition vehicle in the country on the AltX in June last year. 

The company has now successfully transitioned from the AltX to the main board general segment of the JSE in just 15 months. 
]]></description>
            <author>Marleny Arnoldi</author>
            <category>MANUFACTURING</category>
            <pubDate>Mon, 29 Sep 2025 15:57:00 +0200</pubDate>
        <a_id>706599</a_id>
        <updated>1759209140</updated>
        <published>1759154220</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>1</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001228592_resized_jseexecutivesammokorosileftcilocybinceogabrieltheronmiddleandvaldenereddyjsecapitalmarketsdirectorright2025091022.jpeg</image_url>
        <image_title>JSE executive Sam Mokorosi, Cilo Cybin CEO Gabriel Theron and JSE capital markets director Valdene Reddy</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        <attachments><attachment><url>https://cisp.cachefly.net/assets/articles/attachments/95575_2025-09-29_cilo_cybin_jse_listing.mp4</url><size>166044074</size><title>JSE capital markets director Valdene Reddy and Cilo Cybin CEO Gabriel Theron discuss Cilo Cybin's listing on the main board of the JSE</title></attachment></attachments>
        <media:group><media:content url="https://cisp.cachefly.net/assets/articles/attachments/95575_2025-09-29_cilo_cybin_jse_listing.mp4" fileSize="166044074" type="video" medium="video" expression="full"><media:description type="plain">JSE capital markets director Valdene Reddy and Cilo Cybin CEO Gabriel Theron discuss Cilo Cybin's listing on the main board of the JSE</media:description></media:content></media:group>
<enclosure url="https://cisp.cachefly.net/assets/articles/attachments/95575_2025-09-29_cilo_cybin_jse_listing.mp4" length="166044074" type="video/mpeg" />        </item>
        <item>
            <title>Remgro declares higher dividend on good performance by most of its portfolio </title>
            <link>https://www.engineeringnews.co.za/article/remgro-declares-higher-dividend-on-good-performance-by-most-of-its-portfolio-2025-09-23</link>
            <description><![CDATA[Diversified investment holding company Remgro has announced strong results for the financial year ended June 30, supported by sustained momentum in the group’s underlying portfolio of investee companies, together with consistent execution against its stated strategic objective of disciplined capital allocation and active partnership. This has resulted in continued improvements in earnings contributions across the portfolio, with more than 80% of Remgro’s portfolio achieving growth in headline earnings for the period.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>INVESTMENTS </category>
            <pubDate>Tue, 23 Sep 2025 11:39:00 +0200</pubDate>
        <a_id>706269</a_id>
        <updated>1758623137</updated>
        <published>1758620340</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001227644_resized_rainbowfrozenchicken0624reuters1022.jpeg</image_url>
        <image_title>There were significant increased contributions during the year from Mediclinic Group, OUTsurance Group, Rainbow Chicken and RCL Foods </image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
    </channel>
</rss>
